NCT05234996View on ClinicalTrials.gov

The Immersive Experience of Virtual Reality During Chemotherapy in Patients With Early Breast and Gynecological Cancers: the Patient's Dream Study

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

January 20, 2021

Study Completion Date

April 1, 2021

Conditions
Breast Cancer
Interventions
DEVICE

3 Virtual Reality headset (VR Headset),

The VRE will administer through the use of 3 Virtual Reality headset (VR Headset), containing a selection of audiovisual productions made with 360 degrees technology and selected on the basis of content, plot and production dynamics.

Trial Locations (1)

00164

alessandra Fabi, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05234996 - The Immersive Experience of Virtual Reality During Chemotherapy in Patients With Early Breast and Gynecological Cancers: the Patient's Dream Study | Biotech Hunter | Biotech Hunter